Skip to main content

Select Drug Profiles

Practice Management
The Health and Economic Effects of Counterfeit Drugs
Erwin A. Blackstone, PhD, Joseph P. Fuhr, Jr, PhD, Steve Pociask, MA
Stakeholder Perspective
The Hidden Market of Counterfeit Drugs a Concern for All Stakeholders
by James T. Kenney, RPh, MBA
Read More
Conference Highlights AMCP
Pharmacy Management and Health Economics Outcomes
Kate O’Rourke, Medical Writer
Read More
Perspectives
2014: The Year of the Healthcare Consumer
David B. Nash, MD, MBA
Read More
Original Research
Salsalate, an Old, Inexpensive Drug with Potential New Indications: A Review of the Evidence from 3 Recent Studies
Kenneth Anderson, DO, Lance Wehrle, DO, Min Park, DO, Kenneth Nelson, DO, Loida D. Nguyen, PharmD, BCPS, Quang T. Nguyen, DO, FACE, FTOS
Stakeholder Perspective
Considering Salsalate Use in Patients at Risk for Diabetes
Read More
Practice Management
The Economic Burden of Ischemic Stroke and Major Hemorrhage in Medicare Beneficiaries with Nonvalvular Atrial Fibrillation: A Retrospective Claims Analysis
Kathryn Fitch, RN, MEd, Jonah Broulette, ASA, MAAA, Winghan Jacqueline Kwong, PharmD, PhD
Stakeholder Perspective
The Clinical Toll of Nonvalvular Atrial Fibrillation Poses Significant Economic Burden
by Raymond L. Singer, MD, MMM, CPE
Read More
Practice Management
The Impact of 5-HT3RA Use on Cost and Utilization in Patients with Chemotherapy- Induced Nausea and Vomiting: Systematic Review of the Literature
Michael S. Broder, MD, MSHS, Claudio Faria, PharmD, MPH, Annette Powers, PharmD, MBA, Jehangeer Sunderji, MD, Dasha Cherepanov, PhD
Stakeholder Perspective
The Value of Pharmaceuticals in the Prevention and Treatment of CINV
by Atheer A. Kaddis, PharmD
Read More
Introduction
Cancer Care in 2014: Continuing Challenges, New Opportunities
Dalia Buffery, MA, ABD
Read More
Original Research
Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population
Saurabh Ray, PhD, Machaon M. K. Bonafede, PhD, MPH, Nimish A. Mohile, MD, Jeffrey A. Bourret, PharmD
Stakeholder Perspective
Treatment Decisions in the Management of Malignant Gliomas
Read More
Perspectives
Payers’ Management of Oncology Drugs: Opportunities and Challenges
James T. Kenney, RPh, MBA
Read More
Perspectives
Where Is the Fix?
David B. Nash, MD, MBA
Read More
Page 149 of 244
Results 1481 - 1490 of 2434